Volume 7, issue 1, December 2015
80 articles in this issue
-
-
Cognitive impact after short-term exposure to different proton pump inhibitors: assessment using CANTAB software
Authors (first, second and last of 6)
-
Microstate connectivity alterations in patients with early Alzheimer’s disease
Authors (first, second and last of 9)
-
APLP1 as a cerebrospinal fluid biomarker for γ-secretase modulator treatment
Authors (first, second and last of 7)
-
In vivo molecular neuroimaging of glucose utilization and its association with fibrillar amyloid-β load in aged APPPS1-21 mice
Authors (first, second and last of 8)
-
Diagnostic value of cerebrospinal fluid Aβ ratios in preclinical Alzheimer’s disease
Authors (first, second and last of 10)
-
Neurogranin and YKL-40: independent markers of synaptic degeneration and neuroinflammation in Alzheimer’s disease
Authors (first, second and last of 11)
-
Role of ABCA7 loss-of-function variant in Alzheimer's disease: a replication study in European–Americans
Authors (first, second and last of 12)
-
Hippocampal atrophy but not white-matter changes predicts the long-term cognitive response to cholinesterase inhibitors in Alzheimer’s disease
Authors (first, second and last of 7)
-
Alzheimer’s disease cerebrospinal fluid biomarkers are not influenced by gravity drip or aspiration extraction methodology
Authors (first, second and last of 25)
-
Central delivery of iodine-125–labeled cetuximab, etanercept and anakinra after perispinal injection in rats: possible implications for treating Alzheimer’s disease
Authors (first, second and last of 6)
-
Improved predictive ability of the Montreal Cognitive Assessment for diagnosing dementia in a community-based study
Authors (first, second and last of 7)
-
Predicting Alzheimer's disease development: a comparison of cognitive criteria and associated neuroimaging biomarkers
Authors (first, second and last of 6)
-
-
Compression or expansion of dementia in Germany? An observational study of short-term trends in incidence and death rates of dementia between 2006/07 and 2009/10 based on German health insurance data
Authors (first, second and last of 4)
-
Association between dental amalgam fillings and Alzheimer’s disease: a population-based cross-sectional study in Taiwan
Authors (first, second and last of 4)
-
New scoring methodology improves the sensitivity of the Alzheimer’s Disease Assessment Scale-Cognitive subscale (ADAS-Cog) in clinical trials
Authors (first, second and last of 6)
-
Cerebrospinal fluid levels of IL-6 are decreased and correlate with cognitive status in DLB patients
Authors (first, second and last of 6)
-
Assessing clinicopathological correlation in chronic traumatic encephalopathy: rationale and methods for the UNITE study
Authors (first, second and last of 28)
-
Verbal and non-verbal memory and hippocampal volumes in a memory clinic population
Authors (first, second and last of 4)
-
The Third French Alzheimer Plan: analysis of the influence of a national public health initiative on scientific research productivity and impact
Authors (first, second and last of 4)
-
Cerebrospinal fluid VILIP-1 and YKL-40, candidate biomarkers to diagnose, predict and monitor Alzheimer’s disease in a memory clinic cohort
Authors (first, second and last of 11)
-
Brain metabolism and cerebrospinal fluid biomarkers profile of non-amnestic mild cognitive impairment in comparison to amnestic mild cognitive impairment and normal older subjects
Authors (first, second and last of 13)
-
Re-examining tau-immunoreactive pathology in the population: granulovacuolar degeneration and neurofibrillary tangles
Authors (first, second and last of 6)
-
-
Modulation of Aβ42 in vivo by γ-secretase modulator in primates and humans
Authors (first, second and last of 4)
-
-
An integrated multi-study analysis of intra-subject variability in cerebrospinal fluid amyloid-β concentrations collected by lumbar puncture and indwelling lumbar catheter
Authors (first, second and last of 23)
-
-
Effects of Souvenaid on plasma micronutrient levels and fatty acid profiles in mild and mild-to-moderate Alzheimer’s disease
Authors (first, second and last of 9)
-
A survey of attitudes toward clinical trials and genetic disclosure in autosomal dominant Alzheimer’s disease
Authors (first, second and last of 9)
-
-
Association of cognitive function with glucose tolerance and trajectories of glucose tolerance over 12 years in the AusDiab study
Authors (first, second and last of 5)
-
Diffusion imaging changes in grey matter in Alzheimer’s disease: a potential marker of early neurodegeneration
Authors (first, second and last of 5)
-
The impact of diabetes on cognitive decline: potential vascular, metabolic, and psychosocial risk factors
Authors (first, second and last of 4)
-
-
-
Alzheimer’s disease progression by geographical region in a clinical trial setting
Authors (first, second and last of 11)
-
Post-mortem analysis of neuroinflammatory changes in human Alzheimer’s disease
Authors
This is part of 1 collection:
-
The dynamics of monocytes and microglia in Alzheimer’s disease
Authors
This is part of 1 collection:
-
Characterization of the postsynaptic protein neurogranin in paired cerebrospinal fluid and plasma samples from Alzheimer’s disease patients and healthy controls
Authors (first, second and last of 14)
-
Comparing recruitment, retention, and safety reporting among geographic regions in multinational Alzheimer’s disease clinical trials
Authors (first, second and last of 12)
-
Cumulative impact of health deficits, social vulnerabilities, and protective factors on cognitive dynamics in late life: a multistate modeling approach
Authors (first, second and last of 6)
-
-
Peripheral and central effects of γ-secretase inhibition by semagacestat in Alzheimer’s disease
Authors (first, second and last of 14)
-
A phase Ib multiple ascending dose study of the safety, tolerability, and central nervous system availability of AZD0530 (saracatinib) in Alzheimer’s disease
Authors (first, second and last of 15)
-
-
Co-morbidity and systemic inflammation as drivers of cognitive decline: new experimental models adopting a broader paradigm in dementia research
Authors
This is part of 1 collection:
-
Lung disease as a determinant of cognitive decline and dementia
Authors
This is part of 1 collection:
-
Dementia trials and dementia tribulations: methodological and analytical challenges in dementia research
Authors
This is part of 1 collection:
